StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) stock

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3086% above fair value
$278.70−3.85 (-1.36%)

Close on Nov 17, 2026Market cap $670.92BP/E 42.3Yield 1.84%

Johnson & Johnson total assets

Total assets on the balance sheet at the end of each period.

Johnson & Johnson's total assets was $197.43B at Sep 27, 2026. For fiscal 2025 it was $199.21B, up 10.6% from the year before. Over ten years it grew 4.1% a year on average. The highest annual figure on record is $199.21B in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 28, 2025$199.21B+10.6%
FY2024Dec 29, 2024$180.10B+7.5%
FY2023Dec 31, 2023$167.56B-10.6%
FY2022Jan 1, 2023$187.38B+2.9%
FY2021Jan 2, 2022$182.02B+4.1%
FY2020Jan 3, 2021$174.89B+10.9%
FY2019Dec 29, 2019$157.73B+3.1%
FY2018Dec 30, 2018$152.95B-2.8%
FY2017Dec 31, 2017$157.30B+11.4%
FY2016Jan 1, 2017$141.21B+5.8%
FY2015Jan 3, 2016$133.41B+2.3%
FY2014Dec 28, 2014$130.36B-1.8%
FY2013Dec 29, 2013$132.68B+9.3%
FY2012Dec 30, 2012$121.35B+6.8%
FY2011Jan 1, 2012$113.64B+10.4%
FY2010Jan 2, 2011$102.91B+8.7%
FY2009Jan 3, 2010$94.68B+11.5%
FY2008Dec 28, 2008$84.91B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 2026$197.43B+2.4%
Q2 FY2026Jun 28, 2026$201.06B+4.0%
Q1 FY2026Mar 29, 2026$200.89B+3.7%
Q4 FY2025Dec 28, 2025$199.21B+10.6%
Q3 FY2025Sep 28, 2025$192.82B+8.1%
Q2 FY2025Jun 29, 2025$193.39B+6.8%
Q1 FY2025Mar 30, 2025$193.67B+12.6%
Q4 FY2024Dec 29, 2024$180.10B+7.5%
Q3 FY2024Sep 29, 2024$178.29B+7.4%
Q2 FY2024Jun 30, 2024$181.09B-5.5%
Q1 FY2024Mar 31, 2024$171.97B-12.2%
Q4 FY2023Dec 31, 2023$167.56B-10.6%
Q3 FY2023Oct 1, 2023$166.06B-5.2%
Q2 FY2023Jul 2, 2023$191.69B+7.9%
Q1 FY2023Apr 2, 2023$195.97B+9.9%
Q4 FY2022Jan 1, 2023$187.38B+2.9%
Q3 FY2022Oct 2, 2022$175.12B-2.3%
Q2 FY2022Jul 3, 2022$177.72B+0.7%
Q1 FY2022Apr 3, 2022$178.36B+3.4%
Q4 FY2021Jan 2, 2022$182.02B+4.1%
Q3 FY2021Oct 3, 2021$179.23B+5.0%
Q2 FY2021Jul 4, 2021$176.44B+11.4%
Q1 FY2021Apr 4, 2021$172.56B+11.3%
Q4 FY2020Jan 3, 2021$174.89B+10.9%
Q3 FY2020Sep 27, 2020$170.69B+9.8%
Q2 FY2020Jun 28, 2020$158.38B+2.1%
Q1 FY2020Mar 29, 2020$155.02B+3.3%
Q4 FY2019Dec 29, 2019$157.73B+3.1%
Q3 FY2019Sep 29, 2019$155.52B-0.1%
Q2 FY2019Jun 30, 2019$155.12B-0.2%
Q1 FY2019Mar 31, 2019$150.03B-4.2%
Q4 FY2018Dec 30, 2018$152.95B-2.8%
Q3 FY2018Sep 30, 2018$155.70B+0.0%
Q2 FY2018Jul 1, 2018$155.37B+1.7%
Q1 FY2018Apr 1, 2018$156.63B+8.1%
Q4 FY2017Dec 31, 2017$157.30B+11.4%
Q3 FY2017Oct 1, 2017$155.66B–
Q2 FY2017Jul 2, 2017$152.81B–
Q1 FY2017Apr 2, 2017$144.92B–
Q4 FY2016Jan 1, 2017$141.21B–

More Johnson & Johnson figures

See a number that looks wrong?